title: Properly assessing CD133 as a risk factor for poor prognosis in patients with hepatocellular carcinoma after resection.
authors.affiliation: The Second Hepatobiliary Surgery Department, Affiliated Hospital of Yangtze University, Jingzhou, 434000, People's Republic of China.
authors.forename: Hao-Feng
authors.initials: HF
authors.lastname: Lu
authors.forename: Wei-Ping
authors.initials: WP
authors.lastname: Yuan
authors.forename: Mi
authors.initials: M
authors.lastname: Li
authors.forename: Qiang
authors.initials: Q
authors.lastname: Huang
authors.forename: Jian-Ping
authors.initials: JP
authors.lastname: Liu
authors.forename: Le-Qun
authors.initials: LQ
authors.lastname: Li
authors.forename: Jian-Hong
authors.initials: JH
authors.lastname: Zhong
mesh_terms: D015703:Antigens, CD / Q000235:genetics*; D014408:Biomarkers, Tumor / Q000235:genetics*; D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000473:pathology*; D006023:Glycoproteins / Q000235:genetics*; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000473:pathology*; D014411:Neoplastic Stem Cells / Q000473:pathology*; D010455:Peptides / Q000235:genetics*
chemical_list: D015703:Antigens, CD; D014408:Biomarkers, Tumor; D006023:Glycoproteins; D010455:Peptides